782 related articles for article (PubMed ID: 18294794)
1. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
Sturm G; Kollerits B; Neyer U; Ritz E; Kronenberg F;
Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P
J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
[TBL] [Abstract][Full Text] [Related]
3. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
4. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.
Boes E; Fliser D; Ritz E; König P; Lhotta K; Mann JF; Müller GA; Neyer U; Riegel W; Riegler P; Kronenberg F
J Am Soc Nephrol; 2006 Feb; 17(2):528-36. PubMed ID: 16382017
[TBL] [Abstract][Full Text] [Related]
6. Relationship of uric acid with progression of kidney disease.
Chonchol M; Shlipak MG; Katz R; Sarnak MJ; Newman AB; Siscovick DS; Kestenbaum B; Carney JK; Fried LF
Am J Kidney Dis; 2007 Aug; 50(2):239-47. PubMed ID: 17660025
[TBL] [Abstract][Full Text] [Related]
7. Association of uric acid with change in kidney function in healthy normotensive individuals.
Bellomo G; Venanzi S; Verdura C; Saronio P; Esposito A; Timio M
Am J Kidney Dis; 2010 Aug; 56(2):264-72. PubMed ID: 20385436
[TBL] [Abstract][Full Text] [Related]
8. CKD progression and mortality among older patients with diabetes.
Patel UD; Young EW; Ojo AO; Hayward RA
Am J Kidney Dis; 2005 Sep; 46(3):406-14. PubMed ID: 16129201
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
[TBL] [Abstract][Full Text] [Related]
10. Silent brain infarction and rapid decline of kidney function in patients with CKD: a prospective cohort study.
Kobayashi M; Hirawa N; Morita S; Yatsu K; Kobayashi Y; Yamamoto Y; Saka S; Toya Y; Yasuda G; Umemura S
Am J Kidney Dis; 2010 Sep; 56(3):468-76. PubMed ID: 20537454
[TBL] [Abstract][Full Text] [Related]
11. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
Jones C; Roderick P; Harris S; Rogerson M
Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
[TBL] [Abstract][Full Text] [Related]
12. Predictors of new-onset decline in kidney function in a general middle-european population.
Obermayr RP; Temml C; Knechtelsdorfer M; Gutjahr G; Kletzmayr J; Heiss S; Ponholzer A; Madersbacher S; Oberbauer R; Klauser-Braun R
Nephrol Dial Transplant; 2008 Apr; 23(4):1265-73. PubMed ID: 18039642
[TBL] [Abstract][Full Text] [Related]
13. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
[TBL] [Abstract][Full Text] [Related]
14. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
15. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
16. Pulse pressure and progression of chronic kidney disease.
Arulkumaran N; Diwakar R; Tahir Z; Mohamed M; Kaski JC; Banerjee D
J Nephrol; 2010; 23(2):189-93. PubMed ID: 20119928
[TBL] [Abstract][Full Text] [Related]
17. [Early diagnosis of chronic kidney disease. New insights into creatinine and proteinuria].
Brandenburg V; Floege J
Med Klin (Munich); 2006 Mar; 101 Suppl 1():158-62. PubMed ID: 16802544
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5.
Serrano A; Huang J; Ghossein C; Nishi L; Gangavathi A; Madhan V; Ramadugu P; Ahya SN; Paparello J; Khosla N; Schlueter W; Batlle D
Adv Chronic Kidney Dis; 2007 Jan; 14(1):105-12. PubMed ID: 17200050
[TBL] [Abstract][Full Text] [Related]
19. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
Imai E; Horio M; Yamagata K; Iseki K; Hara S; Ura N; Kiyohara Y; Makino H; Hishida A; Matsuo S
Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462
[TBL] [Abstract][Full Text] [Related]
20. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
